| CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations RS Redis, AM Sieuwerts, MP Look, O Tudoran, C Ivan, R Spizzo, X Zhang, ... Oncotarget 4 (10), 1748, 2013 | 205 | 2013 |
| Scavenger receptor‐mediated uptake of cell‐penetrating peptide nanocomplexes with oligonucleotides K Ezzat, H Helmfors, O Tudoran, C Juks, S Lindberg, K Padari, ... The FASEB Journal 26 (3), 1172-1180, 2012 | 162 | 2012 |
| Sensitive and rapid detection of Chlamydia trachomatis by recombinase polymerase amplification directly from urine samples K Krõlov, J Frolova, O Tudoran, J Suhorutsenko, T Lehto, H Sibul, I Mäger, ... The Journal of Molecular Diagnostics 16 (1), 127-135, 2014 | 150 | 2014 |
| PepFect15, a novel endosomolytic cell-penetrating peptide for oligonucleotide delivery via scavenger receptors S Lindberg, A Muñoz-Alarcón, H Helmfors, D Mosqueira, D Gyllborg, ... International journal of pharmaceutics 441 (1-2), 242-247, 2013 | 62 | 2013 |
| Expression of VEGF, VEGFR, EGFR, COX-2 and MVD in cervical carcinoma, in relation with the response to radio-chemotherapy VM Nagy, R Buiga, I Brie, N Todor, O Tudoran, C Ordeanu, P Virag, ... Rom J Morphol Embryol 52 (1), 53-59, 2011 | 59 | 2011 |
| Early transcriptional pattern of angiogenesis induced by EGCG treatment in cervical tumour cells O Tudoran, O Soritau, O Balacescu, L Balacescu, C Braicu, M Rus, ... Journal of cellular and molecular medicine 16 (3), 520-530, 2012 | 55 | 2012 |
| Gene expression profiling reveals activation of the FA/BRCA pathway in advanced squamous cervical cancer with intrinsic resistance and therapy failure O Balacescu, L Balacescu, O Tudoran, N Todor, M Rus, R Buiga, ... BMC cancer 14, 1-14, 2014 | 52 | 2014 |
| The role of bioactive dietary components in modulating miRNA expression in colorectal cancer LI Gavrilas, C Ionescu, O Tudoran, C Lisencu, O Balacescu, D Miere Nutrients 8 (10), 590, 2016 | 47 | 2016 |
| The many faces of long noncoding RNAs in cancer X Wu, OM Tudoran, GA Calin, M Ivan Antioxidants & Redox Signaling 29 (9), 922-935, 2018 | 35 | 2018 |
| Hypoxia signaling: Challenges and opportunities for cancer therapy M Ivan, ML Fishel, OM Tudoran, KE Pollok, X Wu, PJ Smith Seminars in cancer biology 85, 185-195, 2022 | 26 | 2022 |
| New alginate–pullulan–bioactive glass composites with copper oxide for bone tissue regeneration trials RA Popescu, K Magyari, M Taulescu, A Vulpoi, C Berce, S Bogdan, ... Journal of Tissue Engineering and Regenerative Medicine 12 (10), 2112-2121, 2018 | 26 | 2018 |
| Urinary microRNAs for prostate cancer diagnosis, prognosis, and treatment response: are we there yet? O Balacescu, B Petrut, O Tudoran, D Feflea, L Balacescu, A Anghel, ... Wiley Interdisciplinary Reviews: RNA 8 (6), e1438, 2017 | 25 | 2017 |
| The clinical implications of platelet derived growth factor B, vascular endothelial growth factor and basic fibroblast growth factor in colorectal cancer C Ionescu, I Berindan-Neagoe, C Burz, O Balacescu, L Balacescu, ... J buon 16 (2), 274-6, 2011 | 24 | 2011 |
| Applications of inflammation-derived gingival stem cells for testing the biocompatibility of dental restorative biomaterials A Soancă, M Lupse, M Moldovan, E Pall, M Cenariu, A Roman, ... Annals of Anatomy-Anatomischer Anzeiger 218, 28-39, 2018 | 23 | 2018 |
| Breast cancer-delivered exosomal miRNA as liquid biopsy biomarkers for metastasis prediction: A focus on translational research with clinical applicability O Baldasici, V Pileczki, D Cruceriu, LI Gavrilas, O Tudoran, L Balacescu, ... International Journal of Molecular Sciences 23 (16), 9371, 2022 | 22 | 2022 |
| Breast cancer stem-like cells: Clinical implications and therapeutic strategies OM Tudoran, O Balacescu, I Berindan-Neagoe Clujul Medical 89 (2), 193, 2016 | 21 | 2016 |
| The value of new high-throughput technologies for diagnosis and prognosis in solid tumors R Pinto, S De Summa, D Petriella, O Tudoran, K Danza, S Tommasi Cancer Biomarkers 14 (2-3), 103-117, 2014 | 20 | 2014 |
| Differential peripheral blood gene expression profile based on Her2 expression on primary tumors of breast cancer patients O Tudoran, O Virtic, L Balacescu, L Pop, F Dragla, A Eniu, B Fetica, ... PLoS One 9 (7), e102764, 2014 | 16 | 2014 |
| Early apoptosis signals induced by a low dose of epigallocatechin 3-gallate interfere with apoptotic and cell death pathways I Berindan-Neagoe, C Braicu, O Tudoran, O Balacescu, A Irimi Journal of nanoscience and nanotechnology 12 (3), 2113-2119, 2012 | 15 | 2012 |
| Circulating small EVs miRNAs as predictors of pathological response to neo-adjuvant therapy in breast cancer patients O Baldasici, L Balacescu, D Cruceriu, A Roman, C Lisencu, B Fetica, ... International Journal of Molecular Sciences 23 (20), 12625, 2022 | 14 | 2022 |
